Global law firm Greenberg Traurig, P.A. represented OPKO Health, Inc. in its private offering of $230 million principal amount of 3.75% convertible senior notes due 2029.

OPKO Health used approximately $50 million to repurchase shares of its common stock from purchasers of notes in the offering and approximately $146.3 million for repurchases of its 4.50% convertible senior notes due 2025. It plans to use the remaining proceeds for general corporate purposes.

Greenberg Traurig also assisted the company with a concurrent private placement of approximately $71.1 million principal amount of 3.75% convertible senior notes due 2029 to Frost Gamma Investments Trust, a trust affiliated with OPKO Chairman and CEO Dr. Phillip Frost, as well OPKO CTO and Vice Chair Jane H. Hsiao, among others, in exchange for certain convertible promissory notes.